---
abstract: Myxofibrosarcoma remains obscure in molecular determinants of clinical aggressiveness,
  for which we elucidated implications of SKP2 amplification.
authors: Li CF, Wang JM, Kang HY, Huang CK, Wang JW, Fang FM, Wang YH, Wu WR, Li SH,
  Yu SC, Lee JC, Lan J, Shiue YL, Wu LC and Huang HY.
contact:
  email: ~
  name: Hsuan-Ying Huang
counts:
  biosamples: 15
  samples_acgh: 15
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:22322669
- geo:GSE35483
geo_data:
  geo_json:
    coordinates:
    - 120.31
    - 22.62
    type: Point
  info:
    city: Kaohsiung
    continent: Asia
    country: Taiwan
    label: Kaohsiung, Taiwan, Asia
    precision: city
journal: 'Clin Cancer Res 18, 6 (2012): 1598-610.'
label: 'Li et al. (2012): Characterization of Gene Amplification-Driven Skp2 Overexpression
  in Myxofibrosarcoma: Potential ...'
notes: ~
pmid: 22322669
title: 'Characterization of Gene Amplification-Driven Skp2 Overexpression in Myxofibrosarcoma:
  Potential Implications in Tumor Progression and Therapeutics.'
year: 2012
